These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
236 related articles for article (PubMed ID: 35790417)
1. Cognitive and neuropsychiatric effects of noradrenergic treatment in Alzheimer's disease: systematic review and meta-analysis. David MCB; Del Giovane M; Liu KY; Gostick B; Rowe JB; Oboh I; Howard R; Malhotra PA J Neurol Neurosurg Psychiatry; 2022 Jul; 93(10):1080-90. PubMed ID: 35790417 [TBL] [Abstract][Full Text] [Related]
2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas. Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557 [TBL] [Abstract][Full Text] [Related]
3. Donepezil for dementia due to Alzheimer's disease. Birks JS; Harvey RJ Cochrane Database Syst Rev; 2018 Jun; 6(6):CD001190. PubMed ID: 29923184 [TBL] [Abstract][Full Text] [Related]
8. Noradrenergic Add-on Therapy with Extended-Release Guanfacine in Alzheimer's Disease (NorAD): study protocol for a randomised clinical trial and COVID-19 amendments. Hoang K; Watt H; Golemme M; Perry RJ; Ritchie C; Wilson D; Pickett J; Fox C; Howard R; Malhotra PA Trials; 2022 Aug; 23(1):623. PubMed ID: 35915506 [TBL] [Abstract][Full Text] [Related]
12. Antipsychotics for agitation and psychosis in people with Alzheimer's disease and vascular dementia. Mühlbauer V; Möhler R; Dichter MN; Zuidema SU; Köpke S; Luijendijk HJ Cochrane Database Syst Rev; 2021 Dec; 12(12):CD013304. PubMed ID: 34918337 [TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of hypoglycemic drugs in improving cognitive function in patients with Alzheimer's disease and mild cognitive impairment: A systematic review and network meta-analysis. Wang XC; Chu CL; Li HC; Lu K; Liu CJ; Cai YF; Quan SJ; Zhang SJ Front Neurol; 2022; 13():1018027. PubMed ID: 36530613 [TBL] [Abstract][Full Text] [Related]
14. Behavioural modification interventions for medically unexplained symptoms in primary care: systematic reviews and economic evaluation. Leaviss J; Davis S; Ren S; Hamilton J; Scope A; Booth A; Sutton A; Parry G; Buszewicz M; Moss-Morris R; White P Health Technol Assess; 2020 Sep; 24(46):1-490. PubMed ID: 32975190 [TBL] [Abstract][Full Text] [Related]
18. Systematic review of atorvastatin for the treatment of Alzheimer's disease. Sun Y; Wang G; Pan Z; Chen S Neural Regen Res; 2012 Jun; 7(17):1344-51. PubMed ID: 25657666 [TBL] [Abstract][Full Text] [Related]